Target Price | $127.50 |
Price | $107.53 |
Potential |
18.57%
register free of charge
|
Number of Estimates | 35 |
35 Analysts have issued a price target Boston Scientific 2026 .
The average Boston Scientific target price is $127.50.
This is
18.57%
register free of charge
$147.00
36.71%
register free of charge
$102.22
4.94%
register free of charge
|
|
A rating was issued by 40 analysts: 36 Analysts recommend Boston Scientific to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Boston Scientific stock has an average upside potential 2026 of
18.57%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 16.75 | 20.06 |
17.61% | 19.75% | |
EBITDA Margin | 23.05% | 30.40% |
0.83% | 31.86% | |
Net Margin | 11.06% | 22.23% |
0.36% | 100.91% |
36 Analysts have issued a sales forecast Boston Scientific 2025 . The average Boston Scientific sales estimate is
This results in the following potential growth metrics:
26 Analysts have issued an Boston Scientific EBITDA forecast 2025. The average Boston Scientific EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
37 Boston Scientific Analysts have issued a net profit forecast 2025. The average Boston Scientific net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.25 | 3.01 |
16.82% | 140.80% | |
P/E | 35.70 | |
EV/Sales | 8.50 |
37 Analysts have issued a Boston Scientific forecast for earnings per share. The average Boston Scientific EPS is
This results in the following potential growth metrics and future valuations:
Boston Scientific...
Analyst | Rating | Action | Date |
---|---|---|---|
UBS |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
Wells Fargo |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
Baird |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
Oppenheimer |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
Truist Securities |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
Raymond James |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
Barclays |
Locked
➜
Locked
|
Locked | Jul 24 2025 |
Analyst Rating | Date |
---|---|
Locked
UBS:
Locked
➜
Locked
|
Jul 24 2025 |
Locked
Wells Fargo:
Locked
➜
Locked
|
Jul 24 2025 |
Locked
Baird:
Locked
➜
Locked
|
Jul 24 2025 |
Locked
Oppenheimer:
Locked
➜
Locked
|
Jul 24 2025 |
Locked
Truist Securities:
Locked
➜
Locked
|
Jul 24 2025 |
Locked
Raymond James:
Locked
➜
Locked
|
Jul 24 2025 |
Locked
Barclays:
Locked
➜
Locked
|
Jul 24 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.